A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults
Clinical trial NCT02298179 · COMPLETED
Trial details
- NCT number
- NCT02298179
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-19
- Primary completion
- 2017-03-27
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.